BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

EPA:BIM • FR0013280286

100 EUR
+3.6 (+3.73%)
Last: Feb 27, 2026, 05:36 PM
Fundamental Rating

6

BIM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. While BIM has a great health rating, its profitability is only average at the moment. BIM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year BIM was profitable.
  • In the past year BIM had a positive cash flow from operations.
  • BIM had positive earnings in each of the past 5 years.
  • Each year in the past 5 years BIM had a positive operating cash flow.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

  • BIM has a Return On Assets of 7.04%. This is amongst the best in the industry. BIM outperforms 84.62% of its industry peers.
  • BIM has a Return On Equity of 9.61%. This is in the better half of the industry: BIM outperforms 64.62% of its industry peers.
  • With a decent Return On Invested Capital value of 8.56%, BIM is doing good in the industry, outperforming 72.31% of the companies in the same industry.
  • BIM had an Average Return On Invested Capital over the past 3 years of 10.05%. This is in line with the industry average of 9.73%.
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROIC 8.56%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • With a decent Profit Margin value of 9.17%, BIM is doing good in the industry, outperforming 67.69% of the companies in the same industry.
  • BIM's Profit Margin has been stable in the last couple of years.
  • Looking at the Operating Margin, with a value of 12.38%, BIM is in line with its industry, outperforming 55.38% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BIM has grown nicely.
  • Looking at the Gross Margin, with a value of 56.27%, BIM is in line with its industry, outperforming 50.77% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
Industry RankSector Rank
OM 12.38%
PM (TTM) 9.17%
GM 56.27%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BIM is creating some value.
  • Compared to 1 year ago, BIM has about the same amount of shares outstanding.
  • Compared to 5 years ago, BIM has less shares outstanding
  • Compared to 1 year ago, BIM has an improved debt to assets ratio.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • BIM has an Altman-Z score of 6.18. This indicates that BIM is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 6.18, BIM belongs to the best of the industry, outperforming 90.77% of the companies in the same industry.
  • The Debt to FCF ratio of BIM is 1.15, which is an excellent value as it means it would take BIM, only 1.15 years of fcf income to pay off all of its debts.
  • BIM's Debt to FCF ratio of 1.15 is amongst the best of the industry. BIM outperforms 84.62% of its industry peers.
  • BIM has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
  • BIM has a better Debt to Equity ratio (0.09) than 78.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Altman-Z 6.18
ROIC/WACC1.07
WACC7.98%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

  • BIM has a Current Ratio of 2.27. This indicates that BIM is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of BIM (2.27) is better than 64.62% of its industry peers.
  • A Quick Ratio of 1.30 indicates that BIM should not have too much problems paying its short term obligations.
  • BIM has a Quick ratio of 1.30. This is in the better half of the industry: BIM outperforms 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.3
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

  • The earnings per share for BIM have decreased by -8.45% in the last year.
  • Measured over the past years, BIM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.91% on average per year.
  • The Revenue has grown by 8.28% in the past year. This is quite good.
  • The Revenue has been growing by 8.27% on average over the past years. This is quite good.
EPS 1Y (TTM)-8.45%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%

3.2 Future

  • BIM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.63% yearly.
  • BIM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.84% yearly.
EPS Next Y15.89%
EPS Next 2Y13.86%
EPS Next 3Y13.5%
EPS Next 5Y11.63%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y5.84%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2032 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 25.91, BIM can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of BIM is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 27.11, BIM is valued at the same level.
  • BIM is valuated rather expensively with a Price/Forward Earnings ratio of 19.98.
  • The rest of the industry has a similar Price/Forward Earnings ratio as BIM.
  • The average S&P500 Price/Forward Earnings ratio is at 28.13. BIM is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 25.91
Fwd PE 19.98
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BIM is valued a bit cheaper than the industry average as 70.77% of the companies are valued more expensively.
  • 64.62% of the companies in the same industry are more expensive than BIM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 26.97
EV/EBITDA 11.69
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • BIM has a very decent profitability rating, which may justify a higher PE ratio.
  • BIM's earnings are expected to grow with 13.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.63
PEG (5Y)2.37
EPS Next 2Y13.86%
EPS Next 3Y13.5%

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.97%, BIM is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.14, BIM has a dividend in line with its industry peers.
  • With a Dividend Yield of 0.97, BIM pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.97%

5.2 History

  • On average, the dividend of BIM grows each year by 19.40%, which is quite nice.
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 28.07% of the earnings are spent on dividend by BIM. This is a low number and sustainable payout ratio.
  • The dividend of BIM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.07%
EPS Next 2Y13.86%
EPS Next 3Y13.5%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (2/27/2026, 5:36:15 PM)

100

+3.6 (+3.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04
Earnings (Next)03-04
Inst Owners21.47%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap11.84B
Revenue(TTM)4.12B
Net Income(TTM)378.00M
Analysts75.29
Price Target122.03 (22.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.97%
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP28.07%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.45%
PT rev (3m)-3.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.01%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.62%
Valuation
Industry RankSector Rank
PE 25.91
Fwd PE 19.98
P/S 2.87
P/FCF 26.97
P/OCF 15.03
P/B 3.01
P/tB 4.23
EV/EBITDA 11.69
EPS(TTM)3.86
EY3.86%
EPS(NY)5
Fwd EY5%
FCF(TTM)3.71
FCFY3.71%
OCF(TTM)6.65
OCFY6.65%
SpS34.82
BVpS33.24
TBVpS23.61
PEG (NY)1.63
PEG (5Y)2.37
Graham Number53.73
Profitability
Industry RankSector Rank
ROA 7.04%
ROE 9.61%
ROCE 11.7%
ROIC 8.56%
ROICexc 9.38%
ROICexgc 13.1%
OM 12.38%
PM (TTM) 9.17%
GM 56.27%
FCFM 10.65%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexgc growth 3Y-22.62%
ROICexgc growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.15
Debt/EBITDA 0.36
Cap/Depr 73.43%
Cap/Sales 8.46%
Interest Coverage 250
Cash Conversion 79.94%
Profit Quality 116.09%
Current Ratio 2.27
Quick Ratio 1.3
Altman-Z 6.18
F-Score8
WACC7.98%
ROIC/WACC1.07
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.45%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%-25.82%
EPS Next Y15.89%
EPS Next 2Y13.86%
EPS Next 3Y13.5%
EPS Next 5Y11.63%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%7.46%
Revenue Next Year5.19%
Revenue Next 2Y5.72%
Revenue Next 3Y6.1%
Revenue Next 5Y5.84%
EBIT growth 1Y-1.73%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year64.69%
EBIT Next 3Y25.44%
EBIT Next 5Y17.85%
FCF growth 1Y133.53%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y66.81%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%

BIOMERIEUX / BIM.PA FAQ

What is the ChartMill fundamental rating of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA.


What is the valuation status of BIOMERIEUX (BIM.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.


What is the profitability of BIM stock?

BIOMERIEUX (BIM.PA) has a profitability rating of 6 / 10.


Can you provide the financial health for BIM stock?

The financial health rating of BIOMERIEUX (BIM.PA) is 8 / 10.


How sustainable is the dividend of BIOMERIEUX (BIM.PA) stock?

The dividend rating of BIOMERIEUX (BIM.PA) is 3 / 10 and the dividend payout ratio is 28.07%.